| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |